We are live on ! Find out more
IRD

Opus Genetics
IRD

27 hedge funds and large institutions have $3.19M invested in Opus Genetics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

23% more capital invested

Capital invested by funds: $2.58M → $3.19M (+$605K)

0% more funds holding

Funds holding: 27 → 27 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
27
Holders Change
–
Holders Change %
0%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
2
Closed
4
Calls
$57K
Puts
–
Net Calls
+$57K
Net Calls Change
-$7K

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$21.9K
2
ARTA
A.R.T. Advisors
New York
+$18.4K
3
UBS Group
UBS Group
Switzerland
+$8.11K
4
BlackRock
BlackRock
New York
+$6.33K
5
Bank of America
Bank of America
North Carolina
+$1.54K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$51.3K
2
Citadel Advisors
Citadel Advisors
Florida
-$24K
3
NFC
Northeast Financial Consultants
Connecticut
-$21K
4
Jane Street
Jane Street
New York
-$19K
5
LTFS
Ladenburg Thalmann Financial Services
Florida
-$618
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.98M +$1.47K +19 +0.1%
BlackRock
2
BlackRock
New York
$344K +$6.33K +82 +2%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$260K – – –
Northern Trust
4
Northern Trust
Illinois
$147K – – –
BCM
5
Bridgeway Capital Management
Texas
$95K – – –
VF
6
Virtu Financial
New York
$94K -$51.3K -664 -38%
Zurich Cantonal Bank
7
Zurich Cantonal Bank
Switzerland
$62K – – –
WS
8
Wedbush Securities
California
$45K – – –
HVIA
9
Hudson Valley Investment Advisors
New York
$36K – – –
BMC
10
Benin Management Corp
Connecticut
$25K – – –
TSS
11
Two Sigma Securities
New York
$24K +$21.9K +283 New
Bank of New York Mellon
12
Bank of New York Mellon
New York
$21K – – –
ARTA
13
A.R.T. Advisors
New York
$20K +$18.4K +238 New
UBS Group
14
UBS Group
Switzerland
$13K +$8.11K +105 +202%
Bank of Montreal
15
Bank of Montreal
Ontario, Canada
$9K – – –
NWM
16
Northwest Wealth Management
Iowa
$7K – – –
Morgan Stanley
17
Morgan Stanley
New York
$3K +$155 +2 +6%
CAGAS
18
Capital Advisory Group Advisory Services
Minnesota
$2K – – –
Bank of America
19
Bank of America
North Carolina
$2K +$1.54K +20 New
LTFS
20
Ladenburg Thalmann Financial Services
Florida
$1K -$618 -8 -30%
VCM
21
Vigilant Capital Management
Maine
$1K – – –
Wells Fargo
22
Wells Fargo
California
$1K – – –
APA
23
American Portfolios Advisors
New York
$178 – – –
FDCDDQ
24
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2 – – –
Citadel Advisors
25
Citadel Advisors
Florida
– -$24K -348 Closed
1
2

IRD Hedge Fund Activity: Q3 2018 in Review

27 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2018, worth a combined $3.19M — up 23% from $2.58M a quarter earlier.

Fund positioning in IRD was balanced in Q3 2018: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 2 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $21.9K. The largest seller was Virtu Financial, cutting an estimated $51.3K.

  • 27 institutional investors held Opus Genetics (IRD) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $3.19M of Opus Genetics stock for Q3 2018, up 23% quarter-over-quarter.
  • 4 funds opened new Opus Genetics positions in Q3 2018 and 4 closed out, a net change of 0 holders.
  • The largest Opus Genetics buyer in Q3 2018 was Two Sigma Securities, an estimated $21.9K added.
  • The largest Opus Genetics seller in Q3 2018 was Virtu Financial, an estimated $51.3K sold.

Based on aggregated 13F filings for Q3 2018.